Sandoz ’s Erelzi available for multiple inflammatory disease treatment in Canada
Novartis division Sandoz has made its Erelzi (etanercept) therapy available for the treatment of multiple inflammatory diseases for patients in Canada.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news